Our Approach
LJI researchers are exploring the hypothesis that there’s something in the pancreas driving its own destruction in type 1 diabetes. Scientists have found that beta cells draw harmful T cells to the pancreas prior to the onset of clinical signs of diabetes. This work has led LJI scientists to investigate the theory that there’s something wrong with the beta cells themselves.
One goal at LJI is to unravel the roles of different immune cells, cytokines, and other signaling molecules as type 1 diabetes progresses. The team analyzes human pancreas tissues obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD), and also human isolated islets.
[Read more: Unmasking the pancreas]
By approaching type 1 diabetes from several angles, LJI scientists hope to unlock the root of many autoimmune diseases.
An infectious disease connection
LJI Instructors Mehdi Benkahla, Ph.D., and Estefania Quesada-Masachs, M.D., Ph.D., are investigating how predisposing genes and environmental factors, such as viral infections, may interact and trigger the disease. Several viruses, mainly from the Enterovirus genus have been considered as potential causal agents for type 1 diabetes. Their goals are to shed light on the mechanisms by which viruses trigger or exacerbate type 1 diabetes and to identify potential therapeutic targets to prevent or treat this devastating disease.
A nervous system connection
The pancreas is studded with islets, the cell clusters that house insulin-producing beta cells. In people with type 1 diabetes, the body’s own immune cells head for the islets and start attacking the beta cells. No one knows exactly what triggers this attack.
One clue may lie in the pattern of beta cell death. Many beta cells are killed off in big patches while other beta cells are mysteriously untouched. Something seems to be drawing immune cells to attack specific groups of beta cells while ignoring others.
In a 2020 Science Advances study, LJI researchers reported that the nervous system may be driving this patchy cell die-off. Their new findings in a mouse model suggest that blocking nerve signals to the pancreas could stop patients from ever developing type 1 diabetes.
Examining T cell behavior
It’s long been thought that having “autoreactive” T cells in the pancreas was a sure sign of type 1 diabetes. In 2020, an LJI-led study showed that even healthy people have these cells lurking in the pancreas—in surprisingly high numbers. It appears that high numbers of these T cells in the pancreas are the default—whether you have type 1 diabetes or not. In people with type 1 diabetes, tissue samples showed autoreactive T cells very close to—and even infiltrating—the islets.
As Dr. Quesada-Masachs explains, “Healthy people also have these immune cells, but they do not attack their pancreas, and we actually still do not know why this happens.”
These results add evidence for the theory that type 1 diabetes is not caused by malfunctioning T cells attacking beta cells. Instead, the body is already making these T cells and something in the pancreas is triggering the attack. The findings also suggest that an effective type 1 diabetes therapy would need to be local to the pancreas.
[Read more: A cold case no longer]
Going forward, the researchers plan to take a closer look at how the preproinsulin-specific T cells behave. The team also hopes to investigate other proteins in islets that might attract T cell attacks.
